Last reviewed · How we verify
NCT03381599
Stem Cells After Peripheral Mobilization and Harvest
Phase 1 trial testing Filgrastim Injection in Stem Cells in 10 participants. Completed in 4 September 2019.
4 September 2019
Quick facts
| Lead sponsor | Andrews Research & Education Foundation |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 10 |
| Start date | 28 March 2018 |
| Primary completion | 4 September 2019 |
| Estimated completion | 4 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Filgrastim Injection — full drug profile →
Conditions studied
- Stem Cells — all drugs for Stem Cells →
- Orthopedic Disorder — all drugs for Orthopedic Disorder →
Sponsor
Andrews Research & Education Foundation
Who can join
Adults 19 to 39, male only, with Stem Cells or Orthopedic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study is a controlled laboratory study where stem cell content of bone marrow aspirate will be compared prior to and following pharmaceutical mobilization. Participants who meet the inclusion/exclusion criteria will have a bone marrow sample taken from the iliac crest. The sample will be tested to determine stem cell content and for the presence of proteins which are of interest in orthopedic treatments. Thirty days following the baseline bone marrow collection, participants will receive a subcutaneous injection of Filgrastim daily for four serial days. On the fifth day, a peripheral blood sample will be taken and processed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03381599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Filgrastim Injection
Trials testing the same drug.
- NCT03944915 — De-Escalation Therapy for Human Papillomavirus Negative Disease · Phase 2 · completed
Other recruiting trials for Stem Cells
Currently open trials in the same condition.
- NCT06841328 — Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes · recruiting
- NCT06951074 — Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes · Phase 2, PHASE3 · recruiting
Other Andrews Research & Education Foundation trials
Trials by the same sponsor.
- NCT05582226 — Augmentation of Anterior Cruciate Ligament Reconstruction Using Mesenchymal Stem Cells and Collagen Matrix Carrier · NA · unknown
- NCT05573347 — Cellular Content of Bone Marrow Aspiration, Comparison · unknown
- NCT07213726 — Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System · NA · active not recruiting
- NCT05735899 — Evaluation of the Safety and Efficacy of Meniscal Preservation Surgery · unknown
- NCT05573412 — Comparison of Proliferative Potential of H-PBSC Based on Demographics and Cryopreservation Time · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03381599 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Andrews Research & Education Foundation
- Last refreshed: 6 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03381599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing